AngioDynamics to Present at the J.P. Morgan Healthcare Conference

Rhea-AI Summary

AngioDynamics, Inc. (NASDAQ: ANGO) announced that Jim Clemmer, President and CEO, and Stephen Trowbridge, CFO, will present at the J.P. Morgan 41st Annual Healthcare Conference on January 12, 2023, at 8:15 a.m. PT (11:15 a.m. ET) in San Francisco, CA. This presentation focuses on AngioDynamics' commitment to transforming medical technology aimed at restoring vascular health and enhancing cancer treatment options. A live webcast will be available on the company's website, with a replay following the event.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan 41^st Annual Healthcare Conference at 8:15 a.m. PT (11:15 a.m. ET) on Thursday, January 12, 2023 in San Francisco, CA.

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221220005691/en/

Investor Contact:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

What is the date and time of AngioDynamics' presentation at the J.P. Morgan Healthcare Conference?

AngioDynamics will present on January 12, 2023, at 8:15 a.m. PT (11:15 a.m. ET).

Who are the presenters for AngioDynamics at the conference?

Jim Clemmer, President and CEO, and Stephen Trowbridge, CFO, will present at the conference.

Where can I watch AngioDynamics' presentation live?

The presentation will be available via live webcast on AngioDynamics' website in the 'Investors' section.

What is the main focus of AngioDynamics as a company?

AngioDynamics focuses on restoring healthy blood flow, expanding cancer treatment options, and improving patient quality of life.

Which stock exchange is AngioDynamics listed on?

AngioDynamics is listed on NASDAQ under the ticker symbol ANGO.